Transcriptome-wide mapping of 5-methylcytidine RNA modifications in bacteria, archaea, and yeast reveals m5C within archaeal mRNAs.
Edelheit S, Schwartz S, Mumbach MR, Wurtzel O, Sorek R. · 2013
Read Transcriptome-wide mapping of 5-methylcytidine RNA modifications in bacteria, archaea, and yeast reveals m5C within archaeal mRNAs. by Edelheit S, Schwartz S, Mumbach MR, Wurtzel O, Sorek R. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3694839.txt.
Introduction
Edelheit and colleagues mapped a chemical mark on RNA, 5-methylcytidine, across bacteria, an archaeon, and yeast, using bisulfite treatment followed by deep sequencing. The mark was known from transfer and ribosomal RNA, but older methods could only inspect a few abundant molecules at a time.
The survey recovered most known sites and measured marks in sixty-four transfer RNAs, with patterns differing between yeast and the archaeon. The surprise was messenger RNA: the archaeon carried the mark inside its messages, guided by a shared sequence motif. The authors take this as the first evidence that archaea modify their messenger RNA, extending a form of regulation once thought mainly eukaryotic.
Catalog record
| CREATOR | Edelheit S, Schwartz S, Mumbach MR, Wurtzel O, Sorek R. |
|---|---|
| YEAR | 2013 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Transcriptome-Wide Mapping of 5-methylcytidine RNA Modifications in Bacteria, Archaea, and Yeast Reveals m5C within Archaeal mRNAs By Sarit Edelheit, Schraga Schwartz, Maxwell R. Mumbach, Omri Wurtzel, Rotem Sorek, Valerie de Crécy-Lagard Published in: PLoS Genetics DOI: 10.1371/journal.pgen.1003602 ABSTRACT The presence of 5-methylcytidine (m5C) in tRNA and rRNA molecules of a wide variety of organisms was first observed more than 40 years ago. However, detection of this modification was limited to specific, abundant, RNA species, due to the usage of low-throughput methods. To obtain a high resolution, systematic, and comprehensive transcriptome-wide overview of m5C across the three domains of life, we used bisulfite treatment on total RNA from both gram positive (B. subtilis) and gram negative (E. coli) bacteria, an archaeon (S. solfataricus) and a eukaryote (S. cerevisiae), followed by massively parallel sequencing. We were able to recover most previously documented m5C sites on rRNA in the four organisms, and identified several novel sites in yeast and archaeal rRNAs. Our analyses also allowed quantification of methylated m5C positions in 64 tRNAs in yeast and archaea, revealing stoichiometric differences between the methylation patterns of these organisms. Molecules of tRNAs in which m5C was absent were also discovered. Intriguingly, we detected m5C sites within archaeal mRNAs, and identified a consensus motif of AUCGANGU that directs methylation in S. solfataricus. Our results, which were validated using m5C-specific RNA immunoprecipitation, provide the first evidence for mRNA modifications in archaea, suggesting that this mode of post-transcriptional regulation extends beyond the eukaryotic domain. INTRODUCTION 5-methylcytidine (m5C) is a modification that occurs both on DNA and RNA. In eukaryotes, this DNA modification has been extensively studied over the past years, and was found to play a crucial role in genomic imprinting, X-chromosome inactivation, and suppression of repetitive elements [1], [2]. Less is known about the distribution and role of m5C sites in RNA. In bacteria, m5C positions were described only in rRNA, whereas in archaea and eukaryotes m5C was mapped to both tRNA and rRNA. In tRNA molecules, m5C sites are typically present at the variable region and the anticodon loop, where they have been shown to stabilize the secondary structure of the tRNA and affect codon identification and tRNA aminoacylation [3]–[5]. For example, m5C at position 40 of the yeast tRNA-Phe enables conformational transition of the entire anticodon loop, inducing Mg2+ binding at a distant site and resulting in structural stabilization [6]. Absence of an m5C modification in the anticodon wobble-base (position 34) of tRNA-Leu in yeast was associated with decreased functionality, observed when nonsense suppressor function was estimated in vivo [7]. Recently, it was shown that various modifications on tRNA, including m5C, are dynamically modulated during cellular responses to several stress conditions, suggesting that these modifications may play a role in cellular response to stress, potentially by mediating translation rates [8], [9]. In rRNA m5C is thought to play a role in translational fidelity [10]. Traditional methods for studying m5C and other RNA modifications include HPLC and mass spectrometry, requiring isolation of the specific RNA molecule being studied to near purity [11], [12]. As opposed to the highly abundant tRNAs and rRNAs, isolation of specific mRNA molecules to purity is experimentally challenging, and hence studies of m5C modifications on mRNA molecules were limited until recently. Indeed, early studies documenting the presence of m5C in mRNA have been controversial; some studies have failed to detect m5C in eukaryotic mRNA [13]–[16], whereas others have identified this modification [17]–[19]. Recently, the presence of m5C in human HeLa mRNA was studied in a global manner, identifying thousands of potential m5C sites within human mRNA [20]. This study utilized RNA bisulfite treatment, which selectively converts C residues, but not m5C, into U residues [21], followed by whole transcriptome sequencing. Such bisulfite treatment is commonly used on DNA sequences when DNA methylation states are studied [22], [23]. However, its usage for RNA m5C methylation interrogation has been limited until recently. As a result, no study has addressed the presence of m5C sites, or any other RNA modification, in prokaryotes in a transcriptome-wide manner, and no modification to bacterial or archaeal mRNA has been described to date. Here, we set out to generate transcriptome wide maps of m5C RNA modification sites in representative model organisms from all three domains of life. We applied bisulfite treatment on total RNA from these organisms, and generated a computational pipeline that identifies methylated positions after accounting for various artifacts. This approach was highly sensitive, and allowed the identification and quantification of the vast majority of known m5C positions in tRNAs and rRNAs in these organisms, as well as the detection of novel positions in these structural RNAs. Anti-m5C RNA immunoprecipitation confirmed our findings. Intriguingly, we detected m5C sites in several mRNAs in archaea, and identified a sequence motif guiding these RNA methylations. This might be suggestive of an additional layer of regulatory complexity present – potentially having functional consequence – on prokaryotic mRNAs. RESULTS To obtain a single-nucleotide resolution overview of m5C sites present in RNA, we extracted total RNA from four model organisms, spanning all three domains of life: the eukaryote Saccharomyces cerevisiae, the archaeon Sulfolobus solfataricus, and the gram positive and negative bacteria, Bacillus subtilis and Escherichia coli, respectively. We treated the RNA with bisulfite using a modified version of the protocol for bisulfite-treatment of DNA,(described in [21]), prepared a pooled cDNA library from the four organisms, and subjected them to massively parallel sequencing (Table 1; Figure 1A). Since all modified sites identified to date have originated from either tRNAs or rRNAs, we used a protocol that enriches for tRNA and rRNA molecules during this initial approach. This allowed us to test the specificity and sensitivity of the assay (Methods). Sequencing reads from this experiment were obtained primarily from tRNA and rRNA, thus validating the approach. Sequencing results gave sufficient coverage (≥5 reads) for all rRNA molecules annotated for the organisms tested, and for 153 of the 187 (82%) annotated tRNA molecules (Table 1). [Figure: Flow of the bisulfite-treatment/RNA-seq experiment.(A) Shown is a schematic representation of RNA molecules; colored boxes represent single bases. Red, blue, green and black represent C, U/T, A, and G residues, respectively. m5C modified cytosine bases are marked by a black circle. Total RNA is bisulfite-treated, leading to deamination of ‘C’ residues into ‘U’, except for methylated residues. Bisulfite-treated RNA is reverse transcribed into cDNA, which is then sequenced via an Illumina HiSeq system. This yields short sequence reads, representing random fragments of the sequenced RNAs. Resulting reads are mapped to the genome using an algorithm that allows mapping of ‘T’ residues in the sequenced cDNAs onto genomic ‘C's. Residues in which ‘C's are found to be consistently non-modified are declared as m5C (red arrow). (B) Flowchart of data analysis and artifact filtering (Methods).] [Table: Sequencing reads covering rRNAs and tRNAs in the studied organisms.] To identify putative methylated positions, we aligned the reads against genomic DNA that was computationally adjusted so that all C residues were converted to T. Overall, we observed that >98% of all sequenced C residues were converted into T following bisulfite conversion and cDNA sequencing, providing statistical power to identify cytosine residues that reproducibly failed to undergo conversion as putative m5C sites (Table 1). For each